Innovating Works

AUGH

Desconocido
BETA3_LVH: A multi center randomized placebo controlled trial of mirabegron a new beta3 adrenergic receptor a... PANEPISTIMIAKO GENIKO NOSOKOMEIO ATTIKON participó en un H2020: H2020-PHC-2014-2015 Patients with cardiovascular risk factors, e.g. hypertension and obesity are at risk of developing heart failure with preserved ejection fra...
2015-04-15 - 2022-08-31 | Financiado
EU-CERT-ICD: Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverte... PANEPISTIMIAKO GENIKO NOSOKOMEIO ATTIKON participó en un FP7: An estimated 500.000 sudden cardiac deaths (SCD) occur each year in the European Union. Patients at risk for SCD may benefit from prophylact...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.